Showing Results for: “type 1 diabetes”

Today, the U.S. Food & Drug Administration (FDA) officially moved insulin to the biologic regulatory framework. All insulins on the market have officially been deemed biologics by the FDA—paving the way for biosimilar and interchangeable insulins. Learn more about what this change means for people living with diabetes at diabetes.org/biologics . LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs & Advocacy for the American Diabetes Association (ADA), issued the following statement: "Insulin is life-sustaining for about seven million Americans—too many of whom can’t afford it

The American Diabetes Association (ADA) announces this year’s National Scientific and Health Care Achievement Award recipients The American Diabetes Association ® (ADA) is proud to announce the recipients of the 2020 National Scientific and Health Care Achievement Awards. The awards recognize academics, health care providers and educators who have contributed to tangible advances in the field of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of diabetes and all its burdens. “I am thrilled to recognize the eight talented

The American Diabetes Association (ADA) welcomes the 2020 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking, innovative medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence. "We are thrilled to welcome the newest members of ADA’s National Board of Directors,” said Tracey D. Brown, Chief Executive Officer of the ADA. “With the help of these talented and dedicated experts, we will continue the important work that leads us closer and

Peter Rossing, MD, DMSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Edwin Bierman Award. This award recognizes a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors. Dr. Rossing will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver his Edwin Bierman Award Lecture, titled “ Linking Kidney and Cardiovascular Complications—Impact on Prognosis and Treatment ,” on

Assiamira Ferrara, MD, PhD, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Norbert Freinkel Award, given in memory of Norbert Freinkel, a dedicated investigator and industry thought leader. The Norbert Freinkel Award honors a researcher who has made outstanding contributions—including scientific publications and presentations—to the understanding and treatment of diabetes in pregnancy. Dr. Ferrara will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. She will deliver the

James Wrobel, DPM, MS, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Roger Pecoraro Award. This award recognizes a researcher who has made significant scientific contributions and demonstrates an untiring commitment to improving the understanding of the detection, treatment, and prevention of diabetic foot complications. Dr. Wrobel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Roger Pecoraro Award Lecture, “ Artificial Intelligence for

The American Diabetes Association (ADA) is honored to welcome the 2019 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence. "The newest members of ADA’s National Board of Directors are respected and trusted leaders within their professions, and we are thankful they are willing to share their time and energy to help us bend the curve on the diabetes epidemic,” said Tracey D. Brown, Chief

Growing reports of dangerous new health conditions, hard-to-manage blood sugar now emerging. A new study released today by the American Diabetes Association® in partnership with dQ&A, finds that growing numbers of people with diabetes have not only been forced to put off needed medical care since the outbreak of COVID-19, but that alarming numbers are struggling to manage their blood glucose levels. Key survey results found: Nearly 1 in 5 Americans with diabetes have skipped doctor’s appointments since the start of the pandemic, principally due to fear of contracting the virus; 1 in 4 people

The American Diabetes Association® (ADA) is honored to announce the recipients of the 2021 National Scientific and Health Care Achievement Awards . The awards recognize academics, health care providers and educators who have contributed to tangible advances in the field of diabetes care and research. Each of these leaders have unwavering dedication to achieving the mission of the ADA: life free of diabetes and all its burdens. “I am thrilled to recognize the eight remarkable individuals receiving the ADA’s National Scientific and Health Care Achievement Awards,” said Tracey D. Brown, Chief

The American Diabetes Association (ADA) welcomes the 2021 Principal Officers and Board of Directors. The 17-member board is comprised of forward-thinking, innovative medical, scientific, education and executive business professionals, who will strategically lead and focus efforts to ensure the ADA continues to uphold the mission upon which it was founded. "I am so excited to announce our 2021 Board of Directors, including five new Board members,” said Tracey D. Brown, Chief Executive Officer of the ADA. “I look forward to the insight and skills that each of these thought leaders will provide